Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients

Diabetes Technology and Therapeutics

Volumn 15, Issue 6, 2013, Pages 461-465

  Madhu, Sri Venkata ^a   Muduli, Subrat Kumar ^a   Avasthi, Rajnish ^a  

^a UCMS AND GTB HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING SYSTEM; DIABETIC PATIENT; DYSGLYCEMIA; EARLY DIAGNOSIS; FEMALE; FIRST DEGREE RELATIVE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; EARLY DIAGNOSIS; FAMILY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INDIA; INSULIN RESISTANCE; MALE; MONITORING, PHYSIOLOGIC; OBESITY; PREDIABETIC STATE; RISK ASSESSMENT; RISK FACTORS;

EID: 84878530247     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0333     Document Type: Article

References (14)

1. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31(Suppl 1): S55-S60.
2. American Diabetes Association: Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl 1):S11-S61.
3. Bonora E, Muggeo M: Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 2001;44:2107-2114. (Pubitemid 34015463)
4. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J: Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004;164:2090-2095. (Pubitemid 39410797)
5. Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ: Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999;42:1050-1054. (Pubitemid 29408800)
6. Moore KB: Glucose fluctuations and oxidative stress. JAMA 2006;296:1730-1731.
7. Sampson MJ, Gopaul N, Davies IR, Hughes DA, Carrier MJ: Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care 2002;25:537-541. (Pubitemid 41103349)
8. Petrovski G, Dimitrovski C, Milenkovic T: Insulin pump therapy with continuous glucose monitoring improves metabolic control in brittle type 1 diabetes. Prilozi 2007;28: 129-135.
9. Moreau F, Weiller MA, Rosner V, Weiss L, Hasselmann M, Pinget M, Kessler R, Kessler L: Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res 2008;40:502-506.
10. Schiaffini R, Brufani C, Russo B, Fintini D, Migliaccio A, Pecorelli L, Bizzarri C, Lucidi V, Cappa M: Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. Eur J Endocrinol 2010;162:705-710.
11. Zou CC, Liang L, Hong F, Zhao ZY: Glucose metabolism disorder in obese children assessed by continuous glucose monitoring system. World J Pediatr 2008;4:26-30. (Pubitemid 351234086)
12. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR: Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study. Diabetologia 2010;53:1608- 1611.
13. The World Health Organization Western Pacific Region, The International Association for the Study of Obesity, The International Obesity Task Force: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia Pty Ltd., 2000.
14. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.